Literature DB >> 11933210

Molecular basis of familial hypercholesterolemia in Brazil: Identification of seven novel LDLR gene mutations.

Luis A Salazar1, Mario H Hirata, Selma A Cavalli, Edna R Nakandakare, Neusa Forti, Jaime Diament, Sérgio D Giannini, Marcelo C Bertolami, Rosario D C Hirata.   

Abstract

Low-density lipoprotein receptor (LDLR) gene mutations cause familial hypercholesterol-emia (FH), one of the most common single gene disorders. The spectrum of LDLR mutations in Brazil is not known. The aim of this study was the characterization of LDLR mutations in 35 unrelated Brazilian patients with heterozygous FH. The promoter region, the 18 exons and the flanking intron sequences of the LDLR gene were screened by PCR-SSCP analysis and by DNA sequencing. In addition, we have screened the apolipoprotein B gene (APOB) for known mutations (R3500Q and R3531C) that cause Familial defective apo B-100 (FDB) by PCR-RFLP procedure. We found two nonsense (E92X and C371X) and six missense LDLR mutations (R236W, G322S, G352D, A370T, C675W and C677Y), that were previously described in FH patients from other populations. We also found five novel missense [G(-20)R, T476P, V503G, D580H and S652R] and two novel frame shift LDLR mutations (FsR757 and FsS828). Four patients were found to carry two different mutations in the LDLR gene: G352D and A370T (one patient), S652R and C675W (one patient) and T476P and V503G (two patients). APOB mutations were not found. These findings demonstrate that there is a broad spectrum of mutations in the LDLR gene in FH individuals from Brazil. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11933210     DOI: 10.1002/humu.9032

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  5 in total

Review 1.  The panorama of familial hypercholesterolemia in Latin America: a systematic review.

Authors:  Roopa Mehta; Rafael Zubirán; Alexandro J Martagón; Alejandra Vazquez-Cárdenas; Yayoi Segura-Kato; María Teresa Tusié-Luna; Carlos A Aguilar-Salinas
Journal:  J Lipid Res       Date:  2016-10-24       Impact factor: 5.922

2.  Impact of 3'UTR genetic variants in PCSK9 and LDLR genes on plasma lipid traits and response to atorvastatin in Brazilian subjects: a pilot study.

Authors:  Tomás Zambrano; Mario Hiroyuki Hirata; Álvaro Cerda; Egidio L Dorea; Gelba A Pinto; Maria C Gusukuma; Marcelo C Bertolami; Luis A Salazar; Rosario Dominguez Crespo Hirata
Journal:  Int J Clin Exp Med       Date:  2015-04-15

3.  A new mouse mutant for the LDL receptor identified using ENU mutagenesis.

Authors:  Karen L Svenson; Nadav Ahituv; Rebecca S Durgin; Holly Savage; Phyllis A Magnani; Oded Foreman; Beverly Paigen; Luanne L Peters
Journal:  J Lipid Res       Date:  2008-07-15       Impact factor: 5.922

4.  Genetic Analysis of Iranian Patients with Familial Hypercholesterolemia

Authors:  Mahdis Ekrami; Maryam Torabi; Soudeh Ghafouri-Fard; Javad Mowla; Bahram Mohammad Soltani; Feyzollah Hashemi-Gorji; Zahra Mohebbi; Mohammad Miryounesi
Journal:  Iran Biomed J       Date:  2017-07-23

5.  Next-generation-sequencing-based identification of familial hypercholesterolemia-related mutations in subjects with increased LDL-C levels in a latvian population.

Authors:  Ilze Radovica-Spalvina; Gustavs Latkovskis; Ivars Silamikelis; Davids Fridmanis; Ilze Elbere; Karlis Ventins; Guna Ozola; Andrejs Erglis; Janis Klovins
Journal:  BMC Med Genet       Date:  2015-09-28       Impact factor: 2.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.